Key Record Dates
ClinicalTrials.gov Identifier: | NCT05462639 |
---|---|
Brief Title: | Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17) |
First Submitted : | June 20, 2022 |
First Submitted that Met QC Criteria : | July 15, 2022 |
First Posted : | July 18, 2022 |
Last Update Submitted that Met QC Criteria : | March 1, 2024 |
Last Update Posted : | March 4, 2024 |